Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative computed tomography

Dheyaa Alkhanfar, Yousef Shahin, Faisal Alandejani, Krit Dwivedi, Samer Alabed, Chris Johns, Allan Lawrie, A.A. Roger Thompson, Alexander M.K. Rothman, Juerg Tschirren, Johanna M. Uthoff, Eric Hoffman, Robin Condliffe, Jim M. Wild, David G. Kiely, Andrew J. Swift
ERJ Open Research 2022 8: 00503-2021; DOI: 10.1183/23120541.00503-2021
Dheyaa Alkhanfar
1Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
2INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dheyaa Alkhanfar
Yousef Shahin
1Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
3Dept of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yousef Shahin
Faisal Alandejani
1Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Faisal Alandejani
Krit Dwivedi
1Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samer Alabed
1Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
3Dept of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samer Alabed
Chris Johns
3Dept of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan Lawrie
1Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Allan Lawrie
A.A. Roger Thompson
1Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
4Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A.A. Roger Thompson
Alexander M.K. Rothman
1Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
4Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juerg Tschirren
5VIDA Diagnostics Inc., Coralville, IA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanna M. Uthoff
6Dept of Computer Science, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Hoffman
7Dept of Radiology, University of Iowa, Iowa City, IA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robin Condliffe
4Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robin Condliffe
Jim M. Wild
1Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
2INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David G. Kiely
2INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
4Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
8These authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David G. Kiely
Andrew J. Swift
1Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK
2INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
8These authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: A.J.Swift@sheffield.ac.uk
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • Supplementary Materials
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Study flowchart. PH: pulmonary hypertension; RHC: right heart catheterisation; PFTs: pulmonary function tests; mPAP: mean pulmonary artery pressure; ILD: interstitial lung disease; CPFE: combined pulmonary fibrosis emphysema syndrome; CLD: chronic lung disease.

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    CT small vessels and coronal images from patients with COPD/emphysema and ILD with no PH, mild to moderate and severe PH. Representative images from patients with COPD/emphysema and ILD with mean values for mPAP and SVV for each group. ILD: interstitial lung disease; PH: pulmonary hypertension; mPAP: mean pulmonary artery pressure; PVR: pulmonary vascular resistance; DLCO: diffusing capacity of the lung for carbon monoxide; SVV: small vessel volume of vessels <1.6 mm.

  • FIGURE 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3

    Correlation of pulmonary vessel volume <1.6 mm in diameter with mPAP and PVR in COPD/emphysema and ILD. PH: pulmonary hypertension; ILD: interstitial lung disease; mPAP: mean pulmonary artery pressure; PVR: pulmonary vascular resistance.

  • FIGURE 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4

    Kaplan–Meier plot showing patients with greater and lesser small vessel volumes (defined as small vessel diameter <1.6 mm) in patients with COPD/emphysema and ILD. ILD: interstitial lung disease; ROC: receiver operating characteristic curve.

Tables

  • Figures
  • Supplementary Materials
  • TABLE 1

    Group comparison of computed tomography-derived vessel parameters in patients with mild to moderate PH (mPAP 21–34 mmHg) versus patients with severe PH (mPAP ≥35 mmHg) in PH-COPD/emphysema and PH-ILD

    COPD/emphysemaILD
    Mild–moderate PHSevere PHMild–moderate PHSevere PH
    Subjects n20243016
    Demographics
     Age years65±1367±1164±1269±16
     Sex %60% female50% male63% female56% male
     WHO functional class (I/II/III/IV) n0/3/16/10/0/18/61/4/23/10/0/10/6
    Right heart catheter data
     mRAP, mmHg6±412±6*6±311±11*
     mPAP, mmHg27±550±10**26±448±9**
     PAWP, mmHg11±315±7*11±311±5
     Cardiac output, L·min−15.75±1.144.44±1.65*5.16±1.263.95±0.93*
     Cardiac index, L·min−1·m−23.30±0.742.36±0.70**2.81±0.732.09±0.53*
     PVR, mmHg233±90709±405**257±143777±242**
     SaO2, %95±293±497±293±3**
     SvO2, %74±662±9**70±463±10*
    ISWT - distance, m231±153105±74**228±15270±85**
    Pulmonary function tests
     FEV1, % pred66±2462±2067±1954±14*
     FVC, % pred94±2181±18*68±2055±17*
     FEV1/FVC ratio, %55±1158±1677±978±9
     TLCO, % pred49.2±23.121.6±11.637.6±20.817.8±11.8*
    All vessel parameters
     Pulmonary vessels <0.8 mm, mL·m−210.6±3.98.1±2.7*6.3±3.34.4±2.3*
     Pulmonary vessels <1.2 mm, mL·m−222.6±7.717.2±5.4*13.2±6.59.4±4.9*
     Pulmonary vessels <1.6 mm, mL·m−234.5±1127±8*20.7±9.415±7.5*
     Lung volume, mL2884±6432395±524*1841±5591526±510
     Total vessel volume, mL91±1779±21*55±1749±24

    Data expressed as mean±sd unless otherwise indicated. PH: pulmonary hypertension; ILD: interstitial lung disease; mPAP: mean pulmonary arterial pressure; WHO: World Health Organization; mRAP: mean right atrial pressure; PAWP: pulmonary artery wedge pressure; PVR: pulmonary vascular resistance; SaO2: oxygen saturation; SvO2: mixed venous oxygen saturation; ISWT: incremental shuttle walk test; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; TLCO: transfer capacity of the lung for the uptake of carbon monoxide (CO). *: significant change between mild to moderate PH and severe PH (p<0.05); **: significant change between mild to moderate PH and severe PH (p<0.01).

    • TABLE 2

      Correlation of computed tomography-derived pulmonary parameters with mPAP and PVR in patients with PH and COPD/emphysema or ILD

      PH–COPD/emphysemaPH–ILD
      mPAP, R value/p-valuePVR, R value/p-valuemPAP, R value/p-valuePVR, R value/p-value
      Subjects n44424644
      Pulmonary vessels <0.8 mm−0.37/0.01−0.25/0.1−0.37/0.01−0.29/0.053
      Pulmonary vessels <1.2 mm−0.37/0.01−0.26/0.1−0.37/0.01−0.30/0.051
      Pulmonary vessels <1.6 mm−0.35/0.02−0.23/0.1−0.37/0.01−0.29/0.06
      Lung volume−0.32/0.03−0.25/0.1−0.32/0.03−0.27/0.07
      Total vessel volume−0.17/0.2−0.16/0.3−0.16/0.2−0.10/0.5

      PH: pulmonary hypertension; ILD: interstitial lung disease; mPAP: mean pulmonary arterial pressure; PVR: pulmonary vascular resistance.

      • TABLE 3

        Comparison of computed tomography derived vessel volumes according to the radiological severity of emphysema and interstitial lung disease (ILD)

        EmphysemaILD
        VariableMildModerateSevereMildModerateSevere
        Pulmonary vessels <0.8 mm, mL·m−27.6+9.611.9#7.9¶,+4.9#5#
        Pulmonary vessels <1.2 mm, mL·m−216.2+2025.2#16.6¶,+10.3#10.3#
        Pulmonary vessels <1.6 mm, mL·m−225.3+31.139.1#25.7¶,+16.5#16.1#
        Total lung volume, mL·m−22353263930142107¶1618#1612
        Total vessel volume, mL·m−271¶,+90#96#70¶,+48#44#

        #: significant difference compared to mild; ¶: significant difference compared to moderate; +: significant difference compared to severe.

        • TABLE 4

          Univariate and multivariate Cox proportional hazards regression analysis

          UnivariateAdjustment for age and sexAdjustment for age, sex and mPAP
          B valueHazard ratiop-valueB valueHazard ratiop-valueB valueHazard ratiop-value
          Age0.031.030.020.031.030.010.021.020.07
          Sex−0.450.630.09−0.490.610.01−0.160.850.58
          mPAP0.051.05<0.010.051.05<0.010.051.05<0.01
          PVR0.0031.003<0.010.0031.003<0.010.0031.003<0.01
          Pulmonary vessels <0.8 mm−0.050.950.02−0.090.920.03−0.040.960.37
          Pulmonary vessels <1.2 mm−0.030.970.03−0.040.960.03−0.020.980.30
          Pulmonary vessels <1.6 mm−0.010.980.03−0.030.970.05−0.010.980.35

          mPAP: mean pulmonary arterial pressure; PVR: pulmonary vascular resistance.

          Supplementary Materials

          • Figures
          • Tables
          • Supplementary Material

            Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.

            Supplementary material 00503-2021.SUPPLEMENT

          PreviousNext
          Back to top
          Vol 8 Issue 2 Table of Contents
          ERJ Open Research: 8 (2)
          • Table of Contents
          • Index by author
          Email

          Thank you for your interest in spreading the word on European Respiratory Society .

          NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

          Enter multiple addresses on separate lines or separate them with commas.
          Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative computed tomography
          (Your Name) has sent you a message from European Respiratory Society
          (Your Name) thought you would like to see the European Respiratory Society web site.
          CAPTCHA
          This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
          Print
          Citation Tools
          Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative computed tomography
          Dheyaa Alkhanfar, Yousef Shahin, Faisal Alandejani, Krit Dwivedi, Samer Alabed, Chris Johns, Allan Lawrie, A.A. Roger Thompson, Alexander M.K. Rothman, Juerg Tschirren, Johanna M. Uthoff, Eric Hoffman, Robin Condliffe, Jim M. Wild, David G. Kiely, Andrew J. Swift
          ERJ Open Research Apr 2022, 8 (2) 00503-2021; DOI: 10.1183/23120541.00503-2021

          Citation Manager Formats

          • BibTeX
          • Bookends
          • EasyBib
          • EndNote (tagged)
          • EndNote 8 (xml)
          • Medlars
          • Mendeley
          • Papers
          • RefWorks Tagged
          • Ref Manager
          • RIS
          • Zotero
          Share
          Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative computed tomography
          Dheyaa Alkhanfar, Yousef Shahin, Faisal Alandejani, Krit Dwivedi, Samer Alabed, Chris Johns, Allan Lawrie, A.A. Roger Thompson, Alexander M.K. Rothman, Juerg Tschirren, Johanna M. Uthoff, Eric Hoffman, Robin Condliffe, Jim M. Wild, David G. Kiely, Andrew J. Swift
          ERJ Open Research Apr 2022, 8 (2) 00503-2021; DOI: 10.1183/23120541.00503-2021
          del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
          Full Text (PDF)

          Jump To

          • Article
            • Abstract
            • Abstract
            • Introduction
            • Methods
            • Results
            • Discussion
            • Supplementary material
            • Footnotes
            • References
          • Figures & Data
          • Info & Metrics
          • PDF

          Subjects

          • Pulmonary vascular disease
          • Lung imaging
          • Tweet Widget
          • Facebook Like
          • Google Plus One

          More in this TOC Section

          Original research articles

          • Biomarkers and low-dose CT in hospitalised AECOPD
          • Lung function in young adulthood
          • CT on lung cancer screening
          Show more Original research articles

          Pulmonary vascular disease

          • Prediction of VʹO2max from 6MWT in pulmonary hypertension
          • Assessment for residual disease after PEA in CTEPH patients
          • Noninvasive follow-up strategy after PEA for CTEPH
          Show more Pulmonary vascular disease

          Related Articles

          Navigate

          • Home
          • Current issue
          • Archive

          About ERJ Open Research

          • Editorial board
          • Journal information
          • Press
          • Permissions and reprints
          • Advertising

          The European Respiratory Society

          • Society home
          • myERS
          • Privacy policy
          • Accessibility

          ERS publications

          • European Respiratory Journal
          • ERJ Open Research
          • European Respiratory Review
          • Breathe
          • ERS books online
          • ERS Bookshop

          Help

          • Feedback

          For authors

          • Instructions for authors
          • Publication ethics and malpractice
          • Submit a manuscript

          For readers

          • Alerts
          • Subjects
          • RSS

          Subscriptions

          • Accessing the ERS publications

          Contact us

          European Respiratory Society
          442 Glossop Road
          Sheffield S10 2PX
          United Kingdom
          Tel: +44 114 2672860
          Email: journals@ersnet.org

          ISSN

          Online ISSN: 2312-0541

          Copyright © 2022 by the European Respiratory Society